Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily103d agobullish
Botox Maker Tops Buy Point, But Here Comes The Earnings Report24/7 Wall St.104d agoneutral
Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a PaycheckMotley Fool112d agoneutral
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?Investor's Business Daily125d agobullish
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into EarningsStockStory128d agoneutral
Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics StocksThe Wall Street Journal130d agoneutral
Galderma Shares Fall After Bid to Launch Botox Rival in U.S. Hits FDA SetbackMotley Fool131d agobullish
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?The Wall Street Journal131d agoneutral
Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial